Show simple item record

dc.contributor.authorYates, LR
dc.contributor.authorKnappskog, S
dc.contributor.authorWedge, D
dc.contributor.authorFarmery, JHR
dc.contributor.authorGonzalez, S
dc.contributor.authorMartincorena, I
dc.contributor.authorAlexandrov, LB
dc.contributor.authorVan Loo, P
dc.contributor.authorHaugland, HK
dc.contributor.authorLilleng, PK
dc.contributor.authorGundem, G
dc.contributor.authorGerstung, M
dc.contributor.authorPappaemmanuil, E
dc.contributor.authorGazinska, P
dc.contributor.authorBhosle, SG
dc.contributor.authorJones, D
dc.contributor.authorRaine, K
dc.contributor.authorMudie, L
dc.contributor.authorLatimer, C
dc.contributor.authorSawyer, E
dc.contributor.authorDesmedt, C
dc.contributor.authorSotiriou, C
dc.contributor.authorStratton, MR
dc.contributor.authorSieuwerts, AM
dc.contributor.authorLynch, AG
dc.contributor.authorMartens, JW
dc.contributor.authorRichardson, AL
dc.contributor.authorTutt, A
dc.contributor.authorLønning, PE
dc.contributor.authorCampbell, PJ
dc.date.accessioned2020-06-15T10:51:34Z
dc.date.issued2017-08-14
dc.identifier.citationCancer cell, 2017, 32 (2), pp. 169 - 184.e7
dc.identifier.issn1535-6108
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3742
dc.identifier.eissn1878-3686
dc.identifier.doi10.1016/j.ccell.2017.07.005
dc.description.abstractPatterns of genomic evolution between primary and metastatic breast cancer have not been studied in large numbers, despite patients with metastatic breast cancer having dismal survival. We sequenced whole genomes or a panel of 365 genes on 299 samples from 170 patients with locally relapsed or metastatic breast cancer. Several lines of analysis indicate that clones seeding metastasis or relapse disseminate late from primary tumors, but continue to acquire mutations, mostly accessing the same mutational processes active in the primary tumor. Most distant metastases acquired driver mutations not seen in the primary tumor, drawing from a wider repertoire of cancer genes than early drivers. These include a number of clinically actionable alterations and mutations inactivating SWI-SNF and JAK2-STAT3 pathways.
dc.formatPrint
dc.format.extent169 - 184.e7
dc.languageeng
dc.language.isoeng
dc.publisherCELL PRESS
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectHumans
dc.subjectBreast Neoplasms
dc.subjectNeoplasm Metastasis
dc.subjectNeoplasm Recurrence, Local
dc.subjectChromosomal Proteins, Non-Histone
dc.subjectTranscription Factors
dc.subjectEvolution, Molecular
dc.subjectMutation
dc.subjectAdult
dc.subjectAged
dc.subjectAged, 80 and over
dc.subjectMiddle Aged
dc.subjectFemale
dc.subjectMale
dc.subjectSTAT3 Transcription Factor
dc.subjectJanus Kinase 2
dc.subjectBiomarkers, Tumor
dc.titleGenomic Evolution of Breast Cancer Metastasis and Relapse.
dc.typeJournal Article
dcterms.dateAccepted2017-07-14
rioxxterms.versionofrecord10.1016/j.ccell.2017.07.005
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2017-08
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfCancer cell
pubs.issue2
pubs.notesNot known
pubs.organisational-group/ICR
pubs.publication-statusPublished
pubs.volume32
pubs.embargo.termsNot known
dc.contributor.icrauthorTutt, Andrew


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0